
|Articles|June 1, 2002
New data drive home key points about testis tumors
The recent review of a large series of patients with bilateral testiculargerm cell cancer treated at Memorial Sloan-Kettering Cancer Center (seearticle, page 8) is interesting and important to practicing urologists whoencounter this disease for three key reasons. First, this study, involving a very large series of patients with bilateraltestis tumors, corroborates the following facts that are well recognizedabout bilateral testicular cancer:
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Elizabeth Nally, MBBS, on decision regret and toxicity perception with adjuvant pembrolizumab
2
Neil Baum, MD, and Abraham Morgentaler, MD, discuss the history of testosterone and prostate cancer
3
The UroOnc Minute: Navigating BCG Maintenance Therapy in NMIBC, With Mark D. Tyson, II, MD, MPH
4
Optimizing care for men with overactive bladder, with Keith Xavier, MD
5






